436 related articles for article (PubMed ID: 34481559)
1. Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoria.
de Blok CJ; Wiepjes CM; van Velzen DM; Staphorsius AS; Nota NM; Gooren LJ; Kreukels BP; den Heijer M
Lancet Diabetes Endocrinol; 2021 Oct; 9(10):663-670. PubMed ID: 34481559
[TBL] [Abstract][Full Text] [Related]
2. The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets.
Wiepjes CM; Nota NM; de Blok CJM; Klaver M; de Vries ALC; Wensing-Kruger SA; de Jongh RT; Bouman MB; Steensma TD; Cohen-Kettenis P; Gooren LJG; Kreukels BPC; den Heijer M
J Sex Med; 2018 Apr; 15(4):582-590. PubMed ID: 29463477
[TBL] [Abstract][Full Text] [Related]
3. Continuation of gender-affirming hormones in transgender people starting puberty suppression in adolescence: a cohort study in the Netherlands.
van der Loos MATC; Hannema SE; Klink DT; den Heijer M; Wiepjes CM
Lancet Child Adolesc Health; 2022 Dec; 6(12):869-875. PubMed ID: 36273487
[TBL] [Abstract][Full Text] [Related]
4. Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol.
van der Loos MATC; Klink DT; Hannema SE; Bruinsma S; Steensma TD; Kreukels BPC; Cohen-Kettenis PT; de Vries ALC; den Heijer M; Wiepjes CM
J Sex Med; 2023 Feb; 20(3):398-409. PubMed ID: 36763938
[TBL] [Abstract][Full Text] [Related]
5. Trends in suicide death risk in transgender people: results from the Amsterdam Cohort of Gender Dysphoria study (1972-2017).
Wiepjes CM; den Heijer M; Bremmer MA; Nota NM; de Blok CJM; Coumou BJG; Steensma TD
Acta Psychiatr Scand; 2020 Jun; 141(6):486-491. PubMed ID: 32072611
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands.
de Blok CJM; Wiepjes CM; Nota NM; van Engelen K; Adank MA; Dreijerink KMA; Barbé E; Konings IRHM; den Heijer M
BMJ; 2019 May; 365():l1652. PubMed ID: 31088823
[TBL] [Abstract][Full Text] [Related]
7. Sexual Desire Changes in Transgender Individuals Upon Initiation of Hormone Treatment: Results From the Longitudinal European Network for the Investigation of Gender Incongruence.
Defreyne J; Elaut E; Kreukels B; Fisher AD; Castellini G; Staphorsius A; Den Heijer M; Heylens G; T'Sjoen G
J Sex Med; 2020 Apr; 17(4):812-825. PubMed ID: 32008926
[TBL] [Abstract][Full Text] [Related]
8. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
[TBL] [Abstract][Full Text] [Related]
9. Bone Mineral Density in Transgender Adolescents Treated With Puberty Suppression and Subsequent Gender-Affirming Hormones.
van der Loos MATC; Vlot MC; Klink DT; Hannema SE; den Heijer M; Wiepjes CM
JAMA Pediatr; 2023 Dec; 177(12):1332-1341. PubMed ID: 37902760
[TBL] [Abstract][Full Text] [Related]
10. Is there a need for liver enzyme monitoring in people using gender-affirming hormone therapy?
Stangl TA; Wiepjes CM; Defreyne J; Conemans E; D Fisher A; Schreiner T; T'Sjoen G; den Heijer M
Eur J Endocrinol; 2021 Apr; 184(4):513-520. PubMed ID: 33524005
[TBL] [Abstract][Full Text] [Related]
11. Gender-affirming hormone treatment: friend or foe? Long-term follow-up of 755 transgender people.
Santi D; Spaggiari G; Marinelli L; Cacciani M; Scipio S; Bichiri A; Profeta A; Granata ARM; Simoni M; Lanfranco F; Manieri C; Ghigo E; Motta G
J Endocrinol Invest; 2024 May; 47(5):1091-1100. PubMed ID: 37889433
[TBL] [Abstract][Full Text] [Related]
12. The Desire and Status of Gender-Affirming Hormone Therapy and Surgery in Transgender Men and Women in China: A National Population Study.
Liu Y; Xin Y; Qi J; Wang H; Hong T; Yang X; Li B; Chang X; Knudson G; Zhao Z; Pan B
J Sex Med; 2020 Nov; 17(11):2291-2298. PubMed ID: 32868262
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Gender-Affirming Hormone Therapy and Cognitive Functioning in Older Transgender Women Compared With Cisgender Women and Men.
van Heesewijk JO; Dreijerink KMA; Wiepjes CM; Kok AAL; van Schoor NM; Huisman M; den Heijer M; Kreukels BPC
J Sex Med; 2021 Aug; 18(8):1434-1443. PubMed ID: 34247950
[TBL] [Abstract][Full Text] [Related]
14. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.
Foster Skewis L; Bretherton I; Leemaqz SY; Zajac JD; Cheung AS
Front Endocrinol (Lausanne); 2021; 12():717766. PubMed ID: 34394009
[TBL] [Abstract][Full Text] [Related]
15. Caring for the transgender adolescent and young adult: Current concepts of an evolving process in the 21st century.
Agana MG; Greydanus DE; Indyk JA; Calles JL; Kushner J; Leibowitz S; Chelvakumar G; Cabral MD
Dis Mon; 2019 Sep; 65(9):303-356. PubMed ID: 31405516
[TBL] [Abstract][Full Text] [Related]
16. Development of Hip Bone Geometry During Gender-Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty.
van der Loos MA; Hellinga I; Vlot MC; Klink DT; den Heijer M; Wiepjes CM
J Bone Miner Res; 2021 May; 36(5):931-941. PubMed ID: 33507568
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Gender-Affirming Hormone Therapy Requirements.
Fernandez JD; Kendjorsky K; Narla A; Villasante-Tezanos AG; Tannock LR
LGBT Health; 2019 Apr; 6(3):101-106. PubMed ID: 30810452
[TBL] [Abstract][Full Text] [Related]
18. Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment.
de Nie I; de Blok CJM; van der Sluis TM; Barbé E; Pigot GLS; Wiepjes CM; Nota NM; van Mello NM; Valkenburg NE; Huirne J; Gooren LJG; van Moorselaar RJA; Dreijerink KMA; den Heijer M
J Clin Endocrinol Metab; 2020 Sep; 105(9):e3293-9. PubMed ID: 32594155
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Gender Dysphoria in Southern Brazil: A Retrospective Study.
Silva DC; Salati LR; Fontanari AMV; Schwarz K; Schneider MA; Soll BBM; Costa AB; Guadagnin F; Hirakata VN; Lobato MIR
Arch Sex Behav; 2021 Nov; 50(8):3517-3526. PubMed ID: 34697689
[TBL] [Abstract][Full Text] [Related]
20. Gender-affirming hormone treatment causes changes in gender phenotype in a 12-lead electrocardiogram.
Saito N; Nagahara D; Ichihara K; Masumori N; Miura T; Takahashi S
Heart Rhythm; 2021 Jul; 18(7):1203-1209. PubMed ID: 33706005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
